参 考 文 献 1. 胡美玲,阎国富,何威.系统性硬皮病的血管病变发病机制研究进展.中国麻风皮肤病杂志,2005,21(7):545~548. 2. 内皮素和硬皮病. 阎国富,刘荣卿,何威. 中国皮肤性病学杂志, 2000, 14(5): 342~343. 3. 王春喜,王太晗,韩丽娜,等. SSC治疗前后血浆血管内皮细胞活性因子测定的临床意义. 放射免疫学杂志,2005,18(1):19~21. 4. 李尚珠,刘春华,黄平平,等. 川芍素对系统性硬皮病患者循环内皮细胞的影响. 中华皮肤科杂志,2001,34(1):34~35. 5.Sator PG, Radakovic S, Schulmeister K, et al. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol, 2009,53(9): Epub ahead of print. 6. Breuckmann F, Stuecker M, Altmeyer P, et al. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res, 2004,296(5):235~239. 7. Trompezinski S, Pernet I, Mayoux C, et al. Transforming growth factor-β1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. Br J Dermatol,2000, 143(3): 539-545. 8. Aiba S, Tabata N, Ohtani H, et al. CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol, 1994, 130(5):593~597. 9. Skobieranda K, Helm KF. Decreased expression of the human progenitor cell antigen (CD34) in morphea. Am J Dermatopathol, 1995, 17(5):471~475. 10. Camacho NR, Sanchez JE, Martin RF, et al. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol, 2001, 45(5):697~699. |